BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Pharm Country

  More Good News in HIV Space as FDA Greenlights Cabenuva Optional Oral Lead-In

  Janssen Pharmaceutical’s treatment for people living with human immunodeficiency virus (HIV-1) has received a label update to now include injectable administration.

  March 25, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  BMS’s Busy Week: a Milestone Approval, Reblozyl Delay and Action in Japan

  The FDA delayed Bristol Myers Squibb’s (BMS) target date for Reblozyl, approved the company’s melanoma drug and Japan accepted BMS’ NDA for Breyanzi.

  March 25, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Pharm Country

  How to Get an Internship in the Pharma Industry

  Applying to your first pharma internship may feel overwhelming, but it doesn’t have to be. Discover how to find, prepare for and be successful in an internship in the pharma industry in our guide.

  March 25, 2022

   · 

  5 min read

   · 

  Kaley Lefevre
• 

  Drug Development

  FDA Concerns Over P13K Inhibitors Snag MEI Pharma, Kyowa Kirin

  The FDA recommends a randomized trial to adequately assess drug efficacy and safety of P13K inhibitor drug candidates.

  March 25, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  A Bone-afied Discovery: Researchers Develop Universal Skeleton Key for Druggable Targets

  Many drugs work by matching up to a pocket or molecular receptor on a protein, like a key into a lock. Dr. David Baker may have found a kind of “skeleton key” to unlock these proteins.

  March 25, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Pharm Country

  Merck to Close Cherokee API Manufacturing Plant, Cut 300 Jobs

  Pharmaceutical giant Merck & Co. has announced the company will shutter the doors of its Cherokee Plant, located in Riverside, Penn.

  March 25, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano, M.S.
• 

  Business

  Roche and BMS Leveraging AI for Solid Tumor Treatment

  Roche has partnered with BMS to utilize two digital pathology platforms that would advance research into solid tumor treatment options for patients.

  March 25, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  French Study Contradicts Cancer Risk from Artificial Sweeteners

  The study suggests that artificial sweeteners, which are readily available in coffee shops and used in diet soft drinks, increase the risks of breast cancer and obesity.

  March 25, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Clinical Catch-Up: Moderna COVID-19 Vaccine for Kids and Much More

  Although it was relatively quiet in COVID-19-related clinical trials, there was plenty of other clinical trial news. Here’s a look.

  March 25, 2022

   · 

  10 min read

   · 

  Mark Terry
• 

  Drug Development

  DMT-Assisted Therapy May Address Root Cause of Major Depressive Disorder

  Small Pharma Inc. is developing a new approach to treat major depressive disorder (MDD) without using SSRIs or standard medications. Here’s what they are using.

  March 25, 2022

   · 

  5 min read

   · 

  Gail Dutton